Daniel Altmann on COVID boosters

FromThe Lancet Respiratory Medicine in conversation with

Start listening View podcast show

Daniel Altmann on COVID boosters

FromThe Lancet Respiratory Medicine in conversation with

ratings:

Length:

16 minutes

Released:

Nov 30, 2021

Format:

Podcast episode

Description

Daniel Atlmann discusses the duration of immune protection from COVID vaccination and the crucial implications for the implementation of booster vaccination programmes.Read the full article:Waning immunity to SARS-CoV-2: implications for vaccine booster strategies - The Lancet Respiratory Medicine

Released:

Nov 30, 2021

Format:

Podcast episode

Titles in the series (100)

Editors speak to the journal’s authors to explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Respiratory Medicine: August 04, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: December 07, 2012 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
11 min listen
The Lancet Respiratory Medicine: October 22, 2013 by The Lancet Respiratory Medicine in conversation with
15 min listen
The Lancet Respiratory Medicine: January 27, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: June 04, 2013 by The Lancet Respiratory Medicine in conversation with
6 min listen
Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: April 16, 2015 by The Lancet Respiratory Medicine in conversation with
7 min listen
The Lancet Respiratory Medicine: March 24, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
The Lancet Respiratory Medicine: August 20, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: February 03, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: December 05, 2013 by The Lancet Respiratory Medicine in conversation with
9 min listen
Defining neonatal ARDS: The Lancet Respiratory Medicine: July 4, 2017 by The Lancet Respiratory Medicine in conversation with
6 min listen
The Lancet Respiratory Medicine: December 23, 2013 by The Lancet Respiratory Medicine in conversation with
5 min listen
The Lancet Respiratory Medicine: March 05, 2013 by The Lancet Respiratory Medicine in conversation with
10 min listen
The role of microbiome: The Lancet Respiratory Medicine: January 2016 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: October 25, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: July 19, 2013 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: December 17, 2014 by The Lancet Respiratory Medicine in conversation with
9 min listen
The Lancet Respiratory Medicine: October 31, 2014 by The Lancet Respiratory Medicine in conversation with
14 min listen
The Lancet Respiratory Medicine: May 13, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen
GOLD 2007 and GOLD 2011: The Lancet Respiratory Medicine: May 18, 2015 by The Lancet Respiratory Medicine in conversation with
7 min listen
The UPBEAT study: The Lancet Respiratory Medicine: July 22, 2015 by The Lancet Respiratory Medicine in conversation with
14 min listen
Eosinophils and asthma: The Lancet Respiratory Medicine: November 2, 2015 by The Lancet Respiratory Medicine in conversation with
13 min listen
The Lancet Respiratory Medicine: May 15, 2013 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: April 07, 2014 by The Lancet Respiratory Medicine in conversation with
10 min listen
The Lancet Respiratory Medicine: October 09, 2014 by The Lancet Respiratory Medicine in conversation with
11 min listen
The Lancet Respiratory Medicine: December 2, 2014 by The Lancet Respiratory Medicine in conversation with
7 min listen
Idiopathic pulmonary fibrosis: The Lancet Respiratory Medicine: March 31, 2016 by The Lancet Respiratory Medicine in conversation with
8 min listen
The Lancet Respiratory Medicine: August 11, 2014 by The Lancet Respiratory Medicine in conversation with
13 min listen
25th issue: The Lancet Respiratory Medicine: March 12, 2015 by The Lancet Respiratory Medicine in conversation with
6 min listen

More Episodes from The Lancet Respiratory Medicine in conversation with

Skip carousel

Anne Chang on the burden of chronic respiratory diseases in Indigenous people by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC by The Lancet Respiratory Medicine in conversation with
10 min listen
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID by The Lancet Respiratory Medicine in conversation with
8 min listen
Sarah Gorst and Tim Nicholson on long COVID outcomes by The Lancet Respiratory Medicine in conversation with
16 min listen
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Keith Chappell on a bivalent recombinant vaccine for COVID-19 by The Lancet Respiratory Medicine in conversation with
8 min listen
James Chalmers on bronchiectasis across Europe by The Lancet Respiratory Medicine in conversation with
12 min listen
Richard Costello on management of uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
12 min listen
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer by The Lancet Respiratory Medicine in conversation with
6 min listen
Carol Hodgson on post-discharge outcomes for ECMO patients by The Lancet Respiratory Medicine in conversation with
19 min listen
Emma Grainger on 10 years of The Lancet Respiratory Medicine by The Lancet Respiratory Medicine in conversation with
13 min listen
Vivienne Kahlmann and Catharina Moor on the TIRED study by The Lancet Respiratory Medicine in conversation with
9 min listen
Yves Lacasse on long-term oxygen therapy for COPD by The Lancet Respiratory Medicine in conversation with
17 min listen
Rachael Evans on living with long COVID by The Lancet Respiratory Medicine in conversation with
13 min listen
Daniel Munblit and Dale Needham on core outcomes post-COVID-19 by The Lancet Respiratory Medicine in conversation with
17 min listen
Daiana Stolz on antibiotic stewardship in pneumonia by The Lancet Respiratory Medicine in conversation with
10 min listen
Ablo Wachinou on sleep disordered breathing in Benin by The Lancet Respiratory Medicine in conversation with
11 min listen
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID by The Lancet Respiratory Medicine in conversation with
15 min listen
Dinh Bui on preterm birth and lung function deficits by The Lancet Respiratory Medicine in conversation with
6 min listen
Ruvim Izĭckson on a joint flu and COVID-19 vaccine by The Lancet Respiratory Medicine in conversation with
9 min listen
Wisia Wedzicha on a vaccine for COPD by The Lancet Respiratory Medicine in conversation with
9 min listen
Eileen Rubin on patient-centered ARDS by The Lancet Respiratory Medicine in conversation with
17 min listen
Michael Kreuter on interstitial lung disease by The Lancet Respiratory Medicine in conversation with
8 min listen
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19 by The Lancet Respiratory Medicine in conversation with
12 min listen
Charles Sprung and authors on end-of-life practices in ICUs globally by The Lancet Respiratory Medicine in conversation with
16 min listen
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma by The Lancet Respiratory Medicine in conversation with
13 min listen
Paul Verweij on COVID-19 associated aspergillosis by The Lancet Respiratory Medicine in conversation with
7 min listen
Ignacio Rubio on COVID-19 pathophysiology and phenotypes by The Lancet Respiratory Medicine in conversation with
9 min listen
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia by The Lancet Respiratory Medicine in conversation with
10 min listen
Fan Chung on chronic cough and long COVID by The Lancet Respiratory Medicine in conversation with
12 min listen

Related podcast episodes

Skip carousel

#160 - Paul Offit, M.D.: The latest on COVID-19 vaccines and their safety, herd immunity, and viral variants: Paul Offit is a pediatrician specializing in infectious diseases and an expert in virology and vaccine development. He currently serves on the FDA committee evaluating COVID-19 vaccines. In this episode, Paul’s second appearance on The Drive, he... by The Peter Attia Drive
86 min listen
TWiV 1034: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate, association between nose picking and SARS-CoV-2 incidence, a... by This Week in Virology
37 min listen
#117 - Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19: In this episode, Stanley Perlman shares insights from his impressive career studying coronaviruses—both the common and more deadly ones, like MERS and SARS. In comparing preceding coronaviruses with SARS-CoV-2, Stanley discusses how other... by The Peter Attia Drive
104 min listen
Coronapod: Variants – what you need to know: Researchers are scrambling to understand the biology of new coronavirus variants and the impact they might have on vaccine efficacy. by Nature Podcast
18 min listen
TWiV 1090: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of respiratory syncytial virus before discussing uptake of the RSV vaccine Abrysvo or the monoclonal anti-RSV antibody nirsevimab to prevent severe disease... by This Week in Virology
36 min listen
COVID-19 vaccine 101: Dr. Drew Weissman discusses mechanisms, efficacy, and vaccinating patients with cancer or HIV: How do the various COVID-19 vaccines work, and when should patients be vaccinated? We tackle these topics and more in this episode. Our host , is joined by , a professor at the University of Pennsylvania, Philadelphia. Dr. Weissman codeveloped the... by Blood & Cancer
24 min listen
The Truth About Healing Long-Haul COVID with Dr. Michael Turner - S2E24 by The DNA Talks Podcast
44 min listen
Audio long read: How your first brush with COVID warps your immunity: Researchers are working to overcome ‘imprinting’, where the immune system responds more strongly to the strain of a virus it first met, weakening response to other strains. by Nature Podcast
16 min listen
TWiV 1066: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses a microbiologist who was harassed during COVID pandemic sues university, use of inactivated poliovirus vaccine for poliovirus outbreak response, safety and immunogenicity of bivalent rsvpref vaccine... by This Week in Virology
44 min listen
TWiV 1084: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the how the pandemic influenced the healthcare job market before he reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus, including... by This Week in Virology
44 min listen
Mask Wearing for COVID-19 Prevention—Summary of CDC Data: Natural experiments comparing coronavirus spread on ships and in hair salons with vs without face masks point to the importance of wearing masks for curbing SARS-CoV-2 spread. John T. Brooks, MD, chief medical officer of the CDC’s COVID-19 response... by JAMA Clinical Reviews
30 min listen
Mask Wearing for COVID-19 Prevention—Summary of CDC Data by Coronavirus (COVID-19) Q&A
30 min listen
TWiV 1108: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of measles, and H51 influenza infection of birds, poultry and cows before and SARS-CoV-2 circulation, before discussing if the original monovalent SARS-CoV-2... by This Week in Virology
43 min listen
JHLT: The Podcast Episode 8: August 2021: Welcome to the August 2021 episode of JHLT: The Podcast. In this special episode, Daniel R. Goldstein, MD, Editor-in-Chief of JHLT, and the JHLT Digital Media Editors, interview ISHLT COVID-19 Task Force Chair Saima Aslam, MD, MS, about the latest,... by JHLT: The Podcast
27 min listen
Florian Krammer - COVID-19 Vaccine Development by Hopkins Biotech Podcast
59 min listen
TWiV 1022: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses autochthonous leprosy in the United States, a systematic review to identify novel clinical characteristics of Mpox virus infection and therapeutic and preventive strategies to combat the virus,... by This Week in Virology
40 min listen
TWiV 1106: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of measles before addressing results of Pfizer’s phase 3 RSV vaccine clinical trial for adults under 60, RSV, influenza and SARS-CoV-2 circulation, differences... by This Week in Virology
44 min listen
TWiV 1050: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the effectiveness of maternal mRNA COVID-19 vaccination during pregnancy against COVID-19–associated hospitalizations in infants aged <6 months during SARS-CoV-2 Omicron predominance, COVID-19... by This Week in Virology
60 min listen
38. A Respiratory Triple Threat: You've probably heard a lot recently about the so-called "tridemic" or "tripledemic." This concurrent impact of COVID-19, influenza and RSV introduced major challenges to our public health system...but taught major lessons, too. David Snyder, director... by Contagious Conversations
27 min listen
T-Cell Immunity and COVID-19—Anthony Tanoto Tan—Duke-NUS Medical School: Senior Research Fellow at Duke-NUS Medical School, Dr. Anthony Tanoto Tan, discusses his work in the field of immunopathology as it relates to both hepatitis B and the SARS-CoV-2 virus responsible for the situation. In this episode, you will learn: ... by Finding Genius Podcast
49 min listen
TWiV 1016: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses surveillance to track progress toward poliomyelitis eradication, genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3, evaluation of Oseltamivir used to prevent... by This Week in Virology
52 min listen
The Web of Long COVID: This episode features Leo Galland, MD, who outlines a systems biology approach to understanding and treating post-COVID syndrome. Dr. Galland created the graphic below to model factors and biological repercussions of long COVID. In the interview, Dr.... by Evolution of Medicine Podcast
53 min listen
Panic at the DisCOVID by Beyond the Abstract
24 min listen
TWiV 1094: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin reviews recent statistics on the circulation of respiratory syncytial virus, influenza and SARS-CoV-2 before discussing revised guidelines for how to treat respiratory viral infection guidelines by the CDC,... by This Week in Virology
53 min listen
TWiV 1088: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses the use of monoclonal antibody therapy to prevent RSV hospitalization of infants and use of GSK’s RSV vaccine Arexy to prevent severe disease following RSV infection in adults between 50-59 years... by This Week in Virology
59 min listen
TWiV 1076: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin highlights global circulation of Mpox virus, reviews the most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus in the US, and discusses the clinical... by This Week in Virology
28 min listen
180: Resiliency Radio with Dr. Jill: Key Updates in LONG COVID with Dr. Bruce Patterson, MD: As the world continues to grapple with the aftermath of the Covid19 pandemic, LONG COVID has emerged as a significant health concern. Many individuals who have recovered from the initial infection are experiencing lingering symptoms, including fatigue... by Resiliency Radio
52 min listen
TWiV 1096: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin highlights measles outbreaks throughout the continental US, reviews recent statistics on the circulation of respiratory syncytial virus, influenza and SARS-CoV-2 before discussing if vaccination protected... by This Week in Virology
41 min listen
TWiV 1020: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin discusses guidance on measles during the summer travel season, the Infectious Diseases Society of America guidelines on the diagnosis of COVID-19: antigen testing, SARS-CoV-2 variants and age-dependent... by This Week in Virology
48 min listen
TWiV 1080: Clinical update with Dr. Daniel Griffin: In his weekly clinical update, Dr. Griffin reviews most recent statistics on the circulation of respiratory syncytial virus, influenza virus and SARS-CoV-2 virus in the US before discussing vaccine effectiveness in children and adolescents, how the... by This Week in Virology
34 min listen

Discover this podcast and so much more

Daniel Altmann on COVID boosters

Daniel Altmann on COVID boosters

Description

Titles in the series (100)

More Episodes from The Lancet Respiratory Medicine in conversation with

Related podcast episodes